Assessment of Noninferiority (and Equivalence) for Simple Crossover Trials Using Bayesian Approach

Mingan Yang ()
Additional contact information
Mingan Yang: San Diego State University

Statistics in Biosciences, 2018, vol. 10, issue 3, No 2, 506-519

Abstract: Abstract To assess the noninferiority or equivalence of a general drug to a standard one, researchers generally use the odds ratio of patient response rates to evaluate the relative treatment efficacy. In this paper, we use a logistic random effects model to test noninferiority and equivalence based on the odds ratio of patient response rates for crossover trials with binary data. We use Bayesian sampling algorithm, data augmentation, and scaled mixture of normal representation to implement the approach and improve efficiency. The performance of the proposed approach is assessed via simulation and real data examples.

Keywords: Binary data; Crossover trial; Equivalence; Noninferiority; Odds ratio (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s12561-017-9209-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:stabio:v:10:y:2018:i:3:d:10.1007_s12561-017-9209-9

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/12561

DOI: 10.1007/s12561-017-9209-9

Access Statistics for this article

Statistics in Biosciences is currently edited by Hongyu Zhao and Xihong Lin

More articles in Statistics in Biosciences from Springer, International Chinese Statistical Association
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().